184 related articles for article (PubMed ID: 22237898)
1. Effects of North American porcine reproductive and respiratory syndrome virus (PRRSV)-based modified live vaccines on preimmunized sows artificially inseminated with European PRRSV-spiked semen.
Han K; Seo HW; Oh Y; Kang I; Park C; Chae C
Clin Vaccine Immunol; 2012 Mar; 19(3):319-24. PubMed ID: 22237898
[TBL] [Abstract][Full Text] [Related]
2. Effect of the modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine on European and North American PRRSV shedding in semen from infected boars.
Han K; Seo HW; Shin JH; Oh Y; Kang I; Park C; Chae C
Clin Vaccine Immunol; 2011 Oct; 18(10):1600-7. PubMed ID: 21832096
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
4. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
[TBL] [Abstract][Full Text] [Related]
5. Heterologous challenge with porcine reproductive and respiratory syndrome (PRRS) vaccine virus: no evidence of reactivation of previous European-type PRRS virus infection.
Bøtner A; Nielsen J; Oleksiewicz MB; Storgaard T
Vet Microbiol; 1999 Aug; 68(3-4):187-95. PubMed ID: 10510038
[TBL] [Abstract][Full Text] [Related]
6. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
9. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
[TBL] [Abstract][Full Text] [Related]
10. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Cho H; Chae C
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
12. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
[TBL] [Abstract][Full Text] [Related]
13. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
[TBL] [Abstract][Full Text] [Related]
14. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
[TBL] [Abstract][Full Text] [Related]
15. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination.
Chrun T; Maze EA; Vatzia E; Martini V; Paudyal B; Edmans MD; McNee A; Manjegowda T; Salguero FJ; Wanasen N; Koonpaew S; Graham SP; Tchilian E
Front Immunol; 2021; 12():758368. PubMed ID: 34858411
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
Jeong J; Choi K; Kang I; Park C; Chae C
Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
[TBL] [Abstract][Full Text] [Related]
18. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
[TBL] [Abstract][Full Text] [Related]
20. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
